Impact of body mass index on immunogenicity of pandemic H1N1 vaccine in children and adults

Journal of Infectious Diseases

Volumn 210, Issue 8, 2014, Pages 1270-1274

  Callahan, S Todd ^a,b   Wolff, Mark ^c   Hill, Heather R ^c   Edwards, Kathryn M ^b   Keitel, Wendy ^d   Atmar, Robert ^d   Patel, Shital ^d   El Sahly, Hana ^d   Munoz, Flor ^d   Glezen, W Paul ^d   Brady, Rebecca ^e   Frenck, Robert ^e   Bernstein, David ^e   Harrison, Christopher ^f   Jackson, Mary Anne ^f   Swanson, Douglas ^f   Newland, Jason ^f   Myers, Angela ^f   Livingston, Robyn A ^f   Walter, Emmanuel ^g   Dolor, Rowena ^g   Schmader, Kenneth ^g   Mulligan, Mark J ^h   Edupuganti, Srilatha ^h   Rouphael, Nadine ^h   Whitaker, Jennifer ^h   Spearman, Paul ^h   Keyserling, Harry ^h   Shane, Andi ^h   Eckard, Allison Ross ^h   Jackson, Lisa A ⁱ   Frey, Sharon E ^j   Belshe, Robert B ^j   Graham, Irene ^j   Anderson, Edwin ^j   Englund, Janet A ^k   Healy, Sara ^k   Winokur, Patricia ^l   Stapleton, Jack ^l   Meier, Jeffrey ^l   Kotloff, Karen ^m   Chen, Wilbur ^m   Hutter, Julia ^m   Stephens, Ina ^m   Wooten, Susan ⁿ   Wald, Anna ^o   more..

^a MONROE CARELL JR CHILDREN S HOSPITAL AT VANDERBILT   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c EMMES CORPORATION   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f CHILDREN S MERCY HOSPITAL   (United States)

^g DUKE UNIVERSITY   (United States)

^h EMORY UNIVERSITY   (United States)

ⁱ GROUP HEALTH RESEARCH INSTITUTE   (United States)

^j SAINT LOUIS UNIVERSITY   (United States)

^k SEATTLE CHILDREN S HOSPITAL   (United States)

^l UNIVERSITY OF IOWA   (United States)

^m UNIVERSITY OF MARYLAND   (United States)

ⁿ UNIVERSITY OF TEXAS   (United States)

^o UNIVERSITY OF WASHINGTON   (United States)

more..

Author keywords

Body mass index; Immune response; Influenza vaccine; Obesity

Indexed keywords

HEMAGGLUTINATION INHIBITING ANTIBODY; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BODY MASS; CHILD; CHILDHOOD OBESITY; DOSE RESPONSE; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNOGENICITY; INFANT; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; MULTICENTER STUDY (TOPIC); PANDEMIC INFLUENZA; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; SEROCONVERSION; SINGLE DRUG DOSE; TREATMENT OUTCOME; AGED; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; OBESITY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; VIROLOGY; YOUNG ADULT;

BODY MASS INDEX; IMMUNE RESPONSE; INFLUENZA VACCINE; OBESITY;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; YOUNG ADULT;

EID: 84911001339     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu245     Document Type: Article

References (15)

1. Louie JK, Acosta M, Samuel MC, et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011;52:301-12.
2. Fezeu L, Julia C, Henegar A, et al. Obesity is associated with higher risk of intensive care unit admission and death in influenza A (H1N1) patients: a systematic review and meta-analysis. Obes Rev 2011;12:653-9.
3. Fiore AE, Uyeki TM, Broder K, et al. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep 2010;59:1-62.
4. Sheridan PA, Paich HA, Handy J, et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012;36:1072-7.
5. Talbot HK, Coleman LA, Crimin K, et al. Association between obesity and vulnerability and serologic response to influenza vaccination in older adults. Vaccine 2012;30:3937-43.
6. Kim YH, Kim JK, Kim DJ, et al. Diet-induced obesity dramatically reduces the efficacy of a 2009 pandemic H1N1 vaccine in a mouse model. J Infect Dis 2012;205:244-51.
7. Zastrow A, Schnitzler P, Eckerle I, Herzog W, Friederich HC. Immunogenicity and safety of H1N1 vaccination in anorexia nervosa-results from a pilot study. Int J Eat Disord 2012;45:146-9.
8. Allende LM, Corell A, Manzanares J, et al. Immunodeficiency associated with anorexia nervosa is secondary and improves after refeeding. Immunology 1998;94:543-51.
9. Prevalence of underweight among children and adolescents: United States, 2007-2008. Centers for Disease Control, National Center for Health Statistics, 2010. http://www.cdc.gov/nchs/data/hestat/under weight-child-07-08/underweight-child-07-08.pdf. Accessed 6 May 2014.
10. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-41.
11. Chen WH, Winokur PL, Edwards KM, et al. Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the US: pandemic preparedness plan in 2009. Vaccine 2012;30:4240-8.
12. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 2002;11:1-190.
13. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. National Institutes of Health. Obes Res 1998;6(suppl 2):51S-209S.
14. Paich HA, Sheridan PA, Handy J, et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity 2013;21:2377-86.
15. Black RE, Victora CG, Walker SP, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet 2013;382:427-51.